Jiang Su Yida Chemical Co.,Ltd

Informe acción SZSE:300721

Capitalización de mercado: CN¥2.3b

Jiang Su Yida ChemicalLtd Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Jiang Su Yida ChemicalLtd has been growing earnings at an average annual rate of 1.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 15.1% per year. Jiang Su Yida ChemicalLtd's return on equity is 1.3%, and it has net margins of 1.6%.

Información clave

1.1%

Tasa de crecimiento de los beneficios

0.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 12.1%
Tasa de crecimiento de los ingresos15.1%
Rentabilidad financiera1.3%
Margen neto1.6%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 42%

Oct 08
Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 42%

There's Been No Shortage Of Growth Recently For Jiang Su Yida ChemicalLtd's (SZSE:300721) Returns On Capital

Sep 28
There's Been No Shortage Of Growth Recently For Jiang Su Yida ChemicalLtd's (SZSE:300721) Returns On Capital

Lacklustre Performance Is Driving Jiang Su Yida Chemical Co.,Ltd's (SZSE:300721) 25% Price Drop

Aug 12
Lacklustre Performance Is Driving Jiang Su Yida Chemical Co.,Ltd's (SZSE:300721) 25% Price Drop

Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 36%

May 21
Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Held Back By Insufficient Growth Even After Shares Climb 36%

Improved Revenues Required Before Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Stock's 41% Jump Looks Justified

Mar 08
Improved Revenues Required Before Jiang Su Yida Chemical Co.,Ltd (SZSE:300721) Stock's 41% Jump Looks Justified

Desglose de ingresos y gastos

Cómo gana y gasta dinero Jiang Su Yida ChemicalLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SZSE:300721 Ingresos, gastos y beneficios (CNY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 241,7812814222
30 Jun 241,8072815322
31 Mar 241,844-518221
31 Dec 231,814-3520025
30 Sep 231,740-6216926
30 Jun 231,673-1815226
31 Mar 231,5504312727
01 Jan 231,5541109024
30 Sep 221,5631629627
30 Jun 221,5231478826
31 Mar 221,5271558225
01 Jan 221,4501328025
30 Sep 211,337944823
30 Jun 211,254655123
31 Mar 211,122215622
31 Dec 201,004-45321
30 Sep 20983-88719
30 Jun 20931-58320
31 Mar 20917-28020
31 Dec 1995478120
30 Sep 19953117220
30 Jun 191,019167521
31 Mar 191,074297422
31 Dec 181,127367622
30 Sep 181,190508723
30 Jun 181,218577434
31 Mar 181,251648227
31 Dec 171,213658723
30 Sep 171,163638517
30 Jun 171,107581040
31 Mar 171,005531010
31 Dec 161,002601000
30 Sep 161,054691020
30 Jun 161,086781000
31 Mar 161,09068990
31 Dec 151,09558990
30 Sep 151,06144970
30 Jun 151,02730960
31 Mar 151,03726920
31 Dec 141,04821890
30 Sep 141,04312880
30 Jun 141,0384870
31 Mar 141,0070870
31 Dec 13977-4860

Ingresos de calidad: 300721 has high quality earnings.

Margen de beneficios creciente: 300721 became profitable in the past.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 300721's earnings have grown by 1.1% per year over the past 5 years.

Acelerando crecimiento: 300721 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Beneficios vs. Industria: 300721 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).


Rentabilidad financiera

Alta ROE: 300721's Return on Equity (1.3%) is considered low.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado